256 related articles for article (PubMed ID: 28283766)
1. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.
Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M
Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
5. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
7. Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?
Freire PV; Watanabe E; dos Santos NR; Bueno C; Bonfá E; de Carvalho JF
Clin Rheumatol; 2014 Mar; 33(3):349-53. PubMed ID: 24420722
[TBL] [Abstract][Full Text] [Related]
8. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
[TBL] [Abstract][Full Text] [Related]
9. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
11. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
13. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
14. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome.
Kapitany A; Tarr T; Gyetvai A; Szodoray P; Tumpek J; Poor G; Szegedi G; Sipka S; Kiss E
Ann N Y Acad Sci; 2009 Sep; 1173():545-51. PubMed ID: 19758197
[TBL] [Abstract][Full Text] [Related]
17. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
Tincani A; Andreoli L; Chighizola C; Meroni PL
Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
19. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus.
Sarter K; Janko C; André S; Muñoz LE; Schorn C; Winkler S; Rech J; Kaltner H; Lorenz HM; Schiller M; Andreoli L; Manfredi AA; Isenberg DA; Schett G; Herrmann M; Gabius HJ
Glycobiology; 2013 Jan; 23(1):12-22. PubMed ID: 22887862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
